Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous ...

The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, including MRI under certain ...

Trinity Biotech is making a serious play in the continuous glucose monitoring space. The Dublin-based company announced positive clinical trial results demonstrating a major technical breakthrough and ...

Medtronic’s CEO, Omar Ishrak, has long expressed a desire to expand the Irish medtech company’s footprint into the much larger type 2 diabetes market. And over the years, the company has made strides ...

DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...

Dexcom is already working on its G8 sensor for continuous glucose monitoring (CGM). But before you get too excited, the product is still a couple of years out, CEO Jake Leach told MD+DI during the J.P ...

For years, Medtronic has trailed behind Dexcom and Abbott in the continuous glucose monitor market. Its newest entry in the space, however, may give its competitors a run for their money. The ...